COMPONENT E-C IMPLANTS WITH TYLAN

ELANCO CANADA LIMITED🇨🇦 Health Canada

Approval Id: 0bb5bb084765fb59
Drug Approval Canada Name: COMPONENT E-C IMPLANTS WITH TYLAN
Product Name: COMPONENT E-C IMPLANTS WITH TYLAN
Status: Marketed
Status Date: 2019-06-12
Original Market Date: 2016-05-18
Drug Class: Veterinary
Dosage Form: Implant
Route Of Administration: Subcutaneous
Schedule: Prescription
Atc Original: Not Applicable
Aig Number: 0347141002
Company Name: ELANCO CANADA LIMITED
Company Address: 401 1919 Minnesota Court Mississauga Ontario Canada L5N 0C9

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Feb 5, 2026

Approval ID

0bb5bb084765fb59

Type

Standard